OpenCapital
Earnings
Stock Screener
Metrics
/
Stocks
Connect AI
Toggle navigation menu
Stocks
Neurocrine Biosciences
Cash Flow Statement
Gain (Loss) on Disposal of Group (Not Discontinued Operation)
Operating
Gain (Loss) on Disposal of Group (Not Discontinued Operation)
Export Chart
Analysis
Statement
Cash Flow Statement
Section
Operating
First reported
Q1 2025
Last reported
Q1 2026
May 5, 2026
Metric ID:
nee_disposal_group_gain_loss
Historical Data
2 periods
Quarterly
Q1 '25
Q1 '26
Value
$0.00
$28.60M
Range
$0.00 – $28.60M
Frequently Asked Questions
What is Neurocrine Biosciences's gain (loss) on disposal of group (not discontinued operation)?
Neurocrine Biosciences (NBIX) reported gain (loss) on disposal of group (not discontinued operation) of $28.60M in Q1 2026.